Navigation Links
StoredIQ Shares Expertise at IQPC's eDiscovery Pharma, Biotech and Medical Device Conference
Date:9/10/2009

AUSTIN, Texas, Sept. 10 /PRNewswire/ --

WHO: Panel of leading eDiscovery experts including Dan Junk, Esq., VP of Business Development, StoredIQ

WHEN: Tuesday, September 15th

9:50 a.m. ET

WHERE: IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries

The Hub Cira Centre -- Philadelphia, PA

TOPIC: Cost-Benefit Analysis of In-house eDiscovery Tools vs. Outsourcing Help

DESCRIPTION:

Product liability lawsuits, patent disputes, class action claims, and regulatory investigations continue to challenge healthcare companies. IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries, focuses on eDiscovery and retention specifically for the highly regulated and litigious drug and medical device markets.

Addressing the cost and benefits of bringing eDiscovery in-house, StoredIQ's Vice President of Business Development, will take part in a panel discussion which includes Dr. Ellen Voorhees, TREC Project Manager from the National Institute of Standards and Technology and Huong Nyugen, Director of Intellectual Property from Impax Laboratories. Panel discussions will center on:

  • Examining how the eDiscovery tools and trends have changed and how they are evolving
  • Persuading the executive management the importance of eDiscovery readiness via a comprehensive cost-benefit analysis
  • Discussing impact of technology that is evolving faster than the laws and identifying areas of increasing importance when vetting eDiscovery technologies
  • Matching the right system with the right internal team

HOW: For more information about the conference and to register, visit: www.ediscoveryevent.com/pharma/

About StoredIQ

StoredIQ is a leading provider of enterprise-class Intelligent Information Management solutions, enabling organizations to gain visibility and control over business-critical information to help meet their compliance, governance and legal discovery requirements. The company provides a range of integrated solutions for fast response to litigation and investigations, for proactive "litigation readiness," and for information protection and risk management, as well as storage management. Industry-leading companies rely on StoredIQ's award-winning technology to streamline their information management and eDiscovery processes to reduce the risk, complexity and cost of litigation. For more information, visit www.storediq.com.

StoredIQ is a trademark of StoredIQ, Inc. All other trademarks may or may not be trademarks or registered trademarks of their respective owners.


'/>"/>
SOURCE StoredIQ
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
3. Neuralstem Shares Accepted for Trading on Amex(R)
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
6. Essilor Cancels 700,000 Shares
7. Helix BioPharma announces $16.9 million private placement of common shares
8. Helix BioPharma closes $16.9 million private placement of common shares
9. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
10. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
11. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... ... 16, 2017 , ... Avomeen & MichBio will be hosting a BioMixer next ... Avomeen Analytical Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are a ... to interact with peers, make new connections and talk bio biz. , Cost:, ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
(Date:2/16/2017)... ... 16, 2017 , ... AxioMed announced today the success of ... surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial Hospital in ... from degenerative disc disease with radiculomyelopathy, as a result of degenerative cervical discs ...
Breaking Biology Technology:
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/3/2017)... Feb. 3, 2017  Texas Biomedical Research Institute announced that ... Larry Schlesinger as the Institute,s new President and CEO. ... May 31, 2017. He is currently the Chair of the ... Center for Microbial Interface Biology at Ohio State University. ... new President and CEO of Texas Biomed," said Dr. ...
Breaking Biology News(10 mins):